130 related articles for article (PubMed ID: 3266795)
21. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
Granados-Soto V; López-Muñoz FJ; Hong E; Flores-Murrieta FJ
J Pharmacol Exp Ther; 1995 Jan; 272(1):352-6. PubMed ID: 7815351
[TBL] [Abstract][Full Text] [Related]
22. Comparative bioavailability of two oral formulations of ketorolac tromethamine: Dolac and Exodol.
Flores-Murrieta FJ; Granados-Soto V; Castañeda-Hernández G; Herrera JE; Hong E
Biopharm Drug Dispos; 1994 Mar; 15(2):129-36. PubMed ID: 8011965
[TBL] [Abstract][Full Text] [Related]
23. Analysis of ketorolac in postmortem blood.
Logan BK; Friel PN; Peterson KL; Predmore DB
J Anal Toxicol; 1995; 19(2):61-4. PubMed ID: 7769787
[TBL] [Abstract][Full Text] [Related]
24. A double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo.
Rice AS; Lloyd J; Miller CG; Bullingham RE; O'sullivan GM
Anaesthesia; 1991 Jul; 46(7):541-4. PubMed ID: 1862891
[TBL] [Abstract][Full Text] [Related]
25. Racemization of ketorolac in aqueous solution.
Brandl M; Conley D; Johnson D; Johnson D
J Pharm Sci; 1995 Sep; 84(9):1045-8. PubMed ID: 8537879
[TBL] [Abstract][Full Text] [Related]
26. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
27. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
[TBL] [Abstract][Full Text] [Related]
28. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.
Fraser-Smith EB; Matthews TR
J Ocul Pharmacol; 1988; 4(2):101-9. PubMed ID: 3262701
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of oral ketorolac in the rat.
Granados-Soto V; Flores-Murrieta FJ
Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):535-8. PubMed ID: 8749226
[TBL] [Abstract][Full Text] [Related]
30. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group.
Yee RW
Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732
[TBL] [Abstract][Full Text] [Related]
31. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt.
Rooks WH; Maloney PJ; Shott LD; Schuler ME; Sevelius H; Strosberg AM; Tanenbaum L; Tomolonis AJ; Wallach MB; Waterbury D
Drugs Exp Clin Res; 1985; 11(8):479-92. PubMed ID: 3879752
[TBL] [Abstract][Full Text] [Related]
32. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.
Ling TL; Combs DL
J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
[TBL] [Abstract][Full Text] [Related]
34. Permeability of pure enantiomers of ketorolac through human cadaver skin.
Roy SD; Chatterjee DJ; Manoukian E; Divor A
J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285
[TBL] [Abstract][Full Text] [Related]
35. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
36. Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers.
Lucker P; Bullingham R; Hooftman L; Lloyd J; Mroszczak E
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):409-14. PubMed ID: 7981925
[TBL] [Abstract][Full Text] [Related]
37. The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone.
Geisslinger G; Peskar BA; Pallapies D; Sittl R; Levy M; Brune K
Thromb Haemost; 1996 Oct; 76(4):592-7. PubMed ID: 8903001
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the analgesic activity of ketorolac in mice.
Domer F
Eur J Pharmacol; 1990 Feb; 177(3):127-35. PubMed ID: 2311674
[TBL] [Abstract][Full Text] [Related]
39. Effect of ketorolac on Candida albicans ocular infection in rabbits.
Fraser-Smith EB; Matthews TR
Arch Ophthalmol; 1987 Feb; 105(2):264-7. PubMed ID: 3492994
[TBL] [Abstract][Full Text] [Related]
40. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
Malhotra M; Majumdar DK
Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
